Two relatively unknown biotechs that are developing promising therapies in this field are Terns Pharmaceuticals ( TERN -7.64%) and Rhythm Pharmaceuticals ( RYTM -2.57%). These biotechs could soar ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a clinical-stage biotech, is pioneering the use of artificial intelligence and ...
Philstar.com on MSN
Breakthrough for Parkinson’s? Spanish pharma proposes gene therapy
A multinational pharmaceutical and biotechnology company here has introduced a medical breakthrough that could provide therapeutic options to patients with Parkinson’s Disease (PD). Gustavo Pesquin, ...
BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...
Malvern biotech company Ocugen signed a deal for its experimental gene therapy with Kwangdong Pharmaceutical to bring in over $25 million.
Supporting Lexicon Pharmaceuticals’ decision to advance the non-opioid analgesic pilavapadin into late-stage ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ ...
A Madison, Wisconsin-based biotech with offices in Cambridge announced an $8 million seed round and a continuing partnership ...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best affordable biotech stocks to invest in now. On September 8, ...
The FDA cracks down on deceptive drug advertising, targeting major pharma and telehealth firms. Read more here.
An exclusive on Sheridan Capital Partners acquiring National Care Systems, a revenue cycle management business focused on post-acute healthcare; a deep dive into how greater awareness about sleep care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback